Blog
Why Shares of Castle Biosciences Plummeted on Monday
Shares of Castle Biosciences (NASDAQ: CSTL) were down more than 47% on Monday afternoon as three analysts lowered their price targets for the medical diagnostic stock. The healthcare stock is down
Why Coinbase, Riot Platforms, and Shiba Inu Are Falling Today
Shares of many cryptocurrencies and crypto-related stocks fell today after the Securities and Exchange Commission (SEC) sued the world's largest crypto exchange, Binance.
Shares of the large
Microsoft's hive mind
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
Microsoft wants
Mastercard sees double
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
Mastercard wants
Neuralink gets a look inside your head
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
Neuralink wants
Wall Street Says These 2 Stocks May Double. Should You Buy Them?
One of the exciting parts of investing is identifying companies that will offer us the next big thing. This could be a game-changing drug or an exciting technology that may transform healthcare. And
Why KeyCorp Stock Dropped 17.1% in May
After falling 10.1% in April, KeyCorp (NYSE: KEY) had another rough month as its stock price dropped 17.1% in May, according to S&P Global Market Intelligence. Year to date, the stock is down about
Here's Why Celsius Stock Surged 31% in May and Is Now at an All-Time High
Shares of energy-drink company Celsius Holdings (NASDAQ: CELH) surged 31.3% in May, according to data provided by S&P Global Market Intelligence, and have gone on to hit new all-time highs in June
Why Bowlero Stock Was Climbing Today
Shares of Bowlero (NYSE: BOWL) were moving higher today on a bullish analyst note from Stifel, which added the stock to its "Select List," and gave it a price target of $25, representing more than a
Why Cloudflare Stock Dropped on Monday
Shares of cybersecurity company Cloudflare (NYSE: NET) tumbled 2.1% through 11:50 a.m. ET on Monday morning.
You can thank UBS for that.
Bright and early Monday morning, Swiss investment bank UBS
4 Takeaways From the FDIC's First-Quarter Banking Report
The Federal Deposit Insurance Corp. (FDIC) recently issued its quarterly report summarizing how the U.S. banking system performed in the first quarter of the year. Obviously, banks had a difficult
Why Palo Alto Networks Stock Popped on Monday
Shares of Palo Alto Networks (NASDAQ: PANW) got a 5% bump Monday morning on the first trading day after it was announced that the stock will be joining the S&P 500 index.
S&P Dow Jones Indices
Why Shares of Day One Pharmaceuticals Are Up Monday
Shares of Day One Pharmaceuticals (NASDAQ: DAWN) were up by more than 13% on Monday morning a day after the clinical-stage biotech released updated trial information regarding its lead therapy. The
2 Best Growth Stocks to Buy Hand Over Fist in June
First, there was the initial steep pandemic market downturn. That was followed shortly by a period in which every growth stock seemed to benefit from a big rebound related to loose monetary policy
Why Ulta Beauty Stock Plunged Nearly 26% in May
Shares of cosmetics retail chain Ulta Beauty (NASDAQ: ULTA) plunged 25.7% in May, according to data provided by S&P Global Market Intelligence. The analyst community grew more cautious about the
Amazon's New Bet Is Primed for Success
In this video, I will talk about Amazon's (NASDAQ: AMZN) potential next big bet, which would add a tremendous amount of value to Prime members and give the company an even bigger competitive
Should Investors Buy Chewy Stock Right Now?
Fool.com contributor and finance professor Parkev Tatevosian reviews Chewy's (NYSE: CHWY) latest earnings release and determines whether Chewy stock is a buy right now.
*Stock prices used were the
3 Reasons to Love Lovesac Stock This Week
One of the more interesting companies reporting fresh financials during this otherwise quiet week for earnings is Lovesac (NASDAQ: LOVE). The furniture maker initially became known for plush luxury
Why Shares of Amedisys Are Jumping Monday
Shares of home healthcare solutions company Amedisys (NASDAQ: AMED) were up more than 14% Monday morning after the company reported that it had received an unsolicited buyout offer from Optum, a
3 Unstoppable Growth Stocks to Buy if There's a Stock Market Sell-Off
The S&P 500 and Nasdaq Composite are up 11% and 27%, respectively, since the beginning of this year as value-seeking investors started nibbling on some stocks that got crushed by rising interest
Beyond Nvidia: 4 Chip Stocks Worth Your Attention
Many investors want to enter the semiconductor market but believe companies like Nvidia (NASDAQ: NVDA) might be overvalued. Here are four chip stocks with numerous growth opportunities, positive
4 Things You Have to Know About Artificial Intelligence
Artificial intelligence continues to be a hot topic for investors, and it seems like the winners are clear. But there may be major changes coming in the next few years as more open-source models are
2 Artificial Intelligence (AI) Growth Stocks Make Up 14% of Cathie Wood's Portfolio
Cathie Wood is the founder and CEO of Ark Invest, an asset management company focused on disruptive technology stocks, especially those that use artificial intelligence (AI). For instance, Ark has
Virgin Galactic Takes Off, So Why Is the Stock Falling?
Virgin Galactic (NYSE: SPCE) completed a space flight and is moving closer to commercial launch, so why is the stock down? In this video, Travis Hoium goes through the recent run-up in the stock and
Is the Warren Buffett of Luxury a Better Investor Than the Legend Himself?
If you think there's been a lot of talk lately about the richest person in the world, you aren't alone. A few years ago, it was Jeff Bezos. Elon Musk recently reclaimed the title. But another man --


